Back to search
FDAFDA · Food and drugs·Recall number D-66201-001

5% Lidocaine HCl and 7.5% Dextrose Injection, USP, 2 mL Single Dose Ampuls, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-4712-01

Published October 9, 2013 · Recall initiated: August 29, 2013

Summary

FDA records drug Class II recall D-66201-001, published October 9, 2013 and initiated August 29, 2013. Recalling firm: Hospira Inc.; Status: Terminated; Reported quantity: 86,400 ampuls; Lot: Lot 23-227-DK. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter; report of visible particulates in the glass ampule

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Hospira Inc.
Distributor
Nationwide
Lot
Lot 23-227-DK
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was 5% Lidocaine HCl and 7.5% Dextrose Injection, USP, 2 mL Single Dose Ampuls, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-4712-01 recalled?

Yes. FDA published recall D-66201-001 on October 9, 2013. Reported hazard: Presence of Particulate Matter; report of visible particulates in the glass ampule

What should I do if I have this product?

Voluntary: Firm initiated · Letter